Category: Uncategorized

Cobitolimod Market Size and Forecast Cobitolimod, an investigational drug for moderate-to-severe ulcerative colitis (UC), targets the substantial unmet need in patients who fail conventional treatments. As a Toll-like receptor 9 (TLR9) agonist,…

Cholecystokinin (CCK) for Pancreas Diagnostic Aid Market Size and Forecast The market for Cholecystokinin (CCK) related to pancreatic diagnostics is specialized, primarily involving its use as an injectable agent to stimulate pancreatic…

MSI-H/dMMR Market Size and Forecast (Relevant to Tebotelimab’s Target) The market for treatments targeting MSI-H/dMMR (Microsatellite Instability-High/deficient Mismatch Repair) cancers is substantial and rapidly expanding. This segment was valued at approximately USD…

Tranylcypromine for OCD: Market Size and Forecast The market specifically for Tranylcypromine in treating Obsessive-Compulsive Disorder (OCD) is considered a niche segment within the broader OCD drug landscape. While Serotonergic Reuptake Inhibitors…

Regorafenib for Liver Market Size and Forecast Regorafenib (Stivarga) holds a significant position as a second-line treatment option for patients with hepatocellular carcinoma (HCC), or liver cancer, who have previously been treated…

NTRK Alt Market Size and Forecast The NTRK fusion-positive advanced solid tumor market is a highly specialized segment within oncology, defined by actionable genomic alterations. Market growth is driven by the efficacy…

PTSD Ganaxolone Market Size and Forecast The Post-Traumatic Stress Disorder (PTSD) treatment market is substantial, valued at around USD 2.28-2.37 billion in 2024/2025, with projections indicating growth up to USD 3.42 billion…

Cleavable Linkers Market Size and Forecast Cleavable linkers form a critical technology segment within the Antibody-Drug Conjugates (ADC) market, enabling the targeted release of cytotoxic payloads inside cancer cells. The global cleavable…

RET Cabozantinib Market Size and Forecast Cabozantinib, marketed as Cometriq and Cabometyx, is a multi-tyrosine kinase inhibitor with specific activity against the RET receptor. Its market size is projected for substantial growth,…

AD Aducanumab Halt Market Size and Forecast The Aducanumab (Aduhelm) market, despite its initial Accelerated Approval for Alzheimer’s disease (AD), faced significant commercial limitations and controversy. Biogen announced in January 2024 that…